No decrease in thrombotic complications in second COVID-19 wave - PACE-CME

No decrease in thrombotic complications in second COVID wave

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Low-dose apixaban noninferior to full dose in cancer-associated VTE
Low-dose apixaban noninferior to full dose in cancer-associated VTE
ACC.25
Low-dose apixaban noninferior to full dose in cancer-associated VTE
- Diego Sadler, MD
Secondary prevention post-ACS: a nurse-led intervention strategy
Secondary prevention post-ACS: a nurse-led intervention strategy
ACC.25
Secondary prevention post-ACS: a nurse-led intervention strategy
- Laura Davidson, MD
Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Patient Case Study: Cancer-Associated Thrombosis
Patient Case Study: Cancer-Associated Thrombosis
MinuteCE®
Patient Case Study: Cancer-Associated Thrombosis
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit